108 related articles for article (PubMed ID: 6532549)
1. Synthesis and structure-activity study of protease inhibitors. III. Amidinophenols and their benzoyl esters.
Yaegashi T; Nunomura S; Okutome T; Nakayama T; Kurumi M; Sakurai Y; Aoyama T; Fujii S
Chem Pharm Bull (Tokyo); 1984 Nov; 32(11):4466-77. PubMed ID: 6532549
[No Abstract] [Full Text] [Related]
2. Synthesis and structure-activity study of protease inhibitors. IV. Amidinonaphthols and related acyl derivatives.
Aoyama T; Okutome T; Nakayama T; Yaegashi T; Matsui R; Nunomura S; Kurumi M; Sakurai Y; Fujii S
Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1458-71. PubMed ID: 4042222
[No Abstract] [Full Text] [Related]
3. [Synthesis of amidinobenzoic acid- and amidinobenzylsulfonic acid esters with antiproteolytic activity].
Wagner G; Vieweg H; Kühmstedt H
Pharmazie; 1973 May; 28(5):288-92. PubMed ID: 4715043
[No Abstract] [Full Text] [Related]
4. [Synthesis of antiproteolytic effective derivatives of benzylamine and benzamidine].
Kazmirowski HG; Landmann H; Walsmann P
Pharmazie; 1969 Jul; 24(7):378-82. PubMed ID: 5810242
[No Abstract] [Full Text] [Related]
5. [Modification of thrombin activity by synthetic serine proteinase inhibitors].
Walsmann P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):471-82. PubMed ID: 4121340
[No Abstract] [Full Text] [Related]
6. [Ethyl esters of N-amidinobenzoyl aminoacids: inhibitory effect on thrombin, blood coagulation and platelet aggregation].
Ferroni R; Orlandini P; Guarneri M; Taddeo U; Franzè D; Bardi A
Farmaco Sci; 1987 Oct; 42(10):709-15. PubMed ID: 3436441
[TBL] [Abstract][Full Text] [Related]
7. [Synthetic inhibitors of serine proteinases. 3. Inhibitory effect of basic ally substituted phenyl carbonic acid esters in comparison with trypsin, plasmin and thrombin].
Stürzebecher J; Markwardt F; Richter P; Wagner G; Walsmann P; Landmann H
Pharmazie; 1974 May; 29(5):337-8. PubMed ID: 4277283
[No Abstract] [Full Text] [Related]
8. Irreversible enzyme inhibitors. CLXV. Proteolytic enzymes. XV. Inhibition of guinea pig complement by derivatives of m-phenoxypropoxybenzamidine.
Baker BR; Cory M
J Med Chem; 1969 Nov; 12(6):1053-6. PubMed ID: 5389147
[No Abstract] [Full Text] [Related]
9. Aromatic tetra-amidines: synthesis of halo-derivatives and their antiproteolytic activity.
Ferroni R; Menegatti E; Guarneri M; Taddeo U; Bolognesi M; Ascenzi P; Amiconi G
Farmaco Sci; 1984 Nov; 39(11):901-9. PubMed ID: 6569842
[TBL] [Abstract][Full Text] [Related]
10. Ethyl esters of N-(3- and N-(4-amidinobenzoyl)(-L-)amino acids: synthesis and antiproteolytic activity towards bovine trypsin and porcine pancreatic kallikrein.
Ferroni R; Menegatti E; Orlandini P; Scalia S; Guarneri M; Bolognesi M; Ascenzi P
Farmaco Sci; 1985 Oct; 40(10):717-29. PubMed ID: 3853512
[TBL] [Abstract][Full Text] [Related]
11. Synthetic low molecular weight inhibitors of serum kallikrein.
Markwardt F; Drawert J; Walsmann P
Biochem Pharmacol; 1974 Aug; 23(16):2247-56. PubMed ID: 4859519
[No Abstract] [Full Text] [Related]
12. [Synthetic inhibitors of serine proteinases. 35. Inhibition action of amidino- and guanidinophenyl derivatives against hemolysis initiated by complement activation].
Hoffmann A; Markwardt F
Pharmazie; 1989 Feb; 44(2):141-4. PubMed ID: 2748697
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity study of protease inhibitors. I. (Guanidinophenyl)propionate and guanidinocinnamate derivatives.
Okutome T; Kawamura H; Taira S; Nakayama T; Nunomura S; Kurumi M; Sakurai Y; Aoyama T; Fujii S
Chem Pharm Bull (Tokyo); 1984 May; 32(5):1854-65. PubMed ID: 6467467
[No Abstract] [Full Text] [Related]
14. [Synthesis of esters of guanidinobenzoic acids and guanidinomethylbenzoic acids with antiproteolytic activity].
Wagner G; Vieweg H; Kühmstedt H
Pharmazie; 1973 May; 28(5):293-6. PubMed ID: 4715044
[No Abstract] [Full Text] [Related]
15. [Synthetic serin protease inhibitors. 1. Inhibition of trypsin, plasmin and thrombin by amidino- and guanidinobenzoic acid esters].
Markwardt F; Walsmann P; Stürzebecher J; Landmann H; Wagner G
Pharmazie; 1973 May; 28(5):326-30. PubMed ID: 4715051
[No Abstract] [Full Text] [Related]
16. Irreversible enzyme inhibitors. 186. Irreversible inhibitors of the C'la component of complement derived from m-(phenoxypropoxy)benzamidine by bridging to a terminal sulfonyl fluoride.
Baker BR; Cory M
J Med Chem; 1971 Sep; 14(9):805-8. PubMed ID: 5140007
[No Abstract] [Full Text] [Related]
17. Synthesis and study of the anti-leukaemic activity of N,N'-substituted amidines and bis-amidines.
Dumont P; Fuks R; Atassi G; Hanocq M
J Pharm Belg; 1985; 40(6):373-86. PubMed ID: 3831292
[No Abstract] [Full Text] [Related]
18. Irreversible enzyme inhibitors. CLXIV. Proteolytic enzymes. XIV. Inhibition of guinea pig complement by meta-substituted benzamidines.
Baker BR; Cory M
J Med Chem; 1969 Nov; 12(6):1049-52. PubMed ID: 5389146
[No Abstract] [Full Text] [Related]
19. Inhibition of the haemolytic complement activity by derivatives of benzamidine.
Hauptmann J; Markwardt F
Biochem Pharmacol; 1977 Feb; 26(4):325-9. PubMed ID: 849323
[No Abstract] [Full Text] [Related]
20. [Synthesis of amidino benzoic acid amides and--anilides, benzoic acid amidino anilides and amidino benzene sulfonic acid amides and--anilides].
Wagner G; Vieweg H; Schubert E
Pharmazie; 1974 Jun; 29(6):383-6. PubMed ID: 4849843
[No Abstract] [Full Text] [Related]
[Next] [New Search]
